demonstrated

Alexa Tsui Appointed Chief Operating Officer of G2Xchange

Source Node:
Time Stamp: January 2, 2024 11:27 AM - Modified On: January 2, 2024 - Published By:
Source Cluster:
Republished By Plato

Alexa Tsui Appointed Chief Operating Officer of G2Xchange Washington DC - G2Xchange, the leader in providing industry news, insights, and market intelligence for the US federal contracting sector, is proud to announce the appointment of Alexa Tsui as its new Chief Operating Officer (COO), effective January 2nd, 2024. Ms. Tsui, a seasoned professional with a career spanning nearly 20 years in leadership roles supporting strategic growth initiatives, brings a wealth of expertise to G2Xchange based on her demonstrated commitment to excellence, her long-standing industry relationships, and a deep understanding of

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:40 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

TapestryX Protocol Rated by the Government Blockchain Association (GBA)

Source Node:
Time Stamp: June 11, 2023 3:09 PM - Modified On: June 11, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington, DC – June 11, 2023 - TapestryX, a layer one blockchain solution, has achieved the venerated distinction of being rated as a Trusted Blockchain Solution for the Banking, Financial Services, and other industries. The Government Blockchain Association (GBA) conducted the evaluation using the highly regarded Blockchain Maturity Model (BMM) and the Banking & Financial Services Supplement. The comprehensive assessment involved a team of esteemed industry experts, including government Chief Information Officers, technology specialists, legal and regulatory professionals, and banking experts. Over several days, the team meticulously analyzed 11 elements

CoinFlip’s New Crypto Platform ‘Olliv’ Aims to Make Cryptocurrency a Simple Part of Everyday Life

Source Node:
Time Stamp: April 27, 2023 12:42 PM - Modified On: April 27, 2023 - Published By:
Source Cluster:
Republished By Plato

Award-Winning Company, CoinFlip, Introduces Accessible and Safe Solutions for ‘Olliv Us’ to Participate in the Digital Economy CHICAGO, April 26, 2023 – CoinFlip, a leading fintech company powered by cryptocurrency, announces today a new chapter of growth and product evolution with the launch of ‘Olliv,’ a safe, inclusive, self-custody-powered crypto platform delivering financial services in the digital economy accessible to everyone. Olliv is breaking down the exclusivity barrier of cryptocurrency and offering a space that welcomes the next generation of investors to the digital economy while serving as an onramp

Regulators at the Ready

Source Node:
Time Stamp: December 16, 2022 2:31 PM - Modified On: December 16, 2022 - Published By:
Source Cluster:
Republished By Plato

Just as bull markets have narratives, so do bear markets, and the overriding narrative of this year has been regulation. Time and again the media has conflated a lack of regulation in crypto with the failures we’ve seen. It’s easy for people to conclude that as soon as regulation comes to crypto, investors will have confidence and flood back into the market. If that was true you would expect to see the stock market flooded with liquidity, but tech stocks are experiencing similar conditions to crypto. Not only is there

World’s biggest deal for Humanoid Robots inked

Source Node:
Time Stamp: August 4, 2022 12:13 PM - Modified On: August 4, 2022 - Published By:
Source Cluster:
Republished By Plato

Robotics innovator Beyond Imagination, Inc. has entered into an agreement with SELF Labs, Inc. to provide at least 1,000 humanoid robots for use in agricultural “grow boxes''. This is believed to be the largest deal of its kind. SELF and Beyond are announcing a partnership to develop automated off-the-grid grow boxes. Each box will be equipped with solar panels, windmills, atmospheric water generators, 5G, and an advanced version of Beyond Imagination’s Beomni™ robot with its Omni-Purpose AI Brain. By aligning the visions of Milan Cheeks of SELF and Dr. Harry

Government Blockchain Association Appoints Sean Kurzweil to its Board of Directors

Source Node:
Time Stamp: March 17, 2022 3:32 AM - Modified On: March 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Washington, D.C., March 16, 2022 - The Government Blockchain Association (GBA) is pleased to announce the nomination of Sean Kurzweil to its Board of Directors. He will also serve as GBA’s CFO. Mr. Kurzweil is a seasoned executive with a multi-industry experience including financial services, technology and manufacturing, supply chain and operations, and healthcare. By day, Sean helps lead population health and value-based care efforts for a national medical group providing acute care services to women and children. His expertise spans strategic financial and operational management, virtual health care and